Despite triple inhaled therapy, many patients with COPD continue to experience frequent and severe exacerbations, leading to hospitalizations, symptom burden, and higher mortality risk. In this expert-led discussion, Diego J. Maselli, MD, FCCP, and Stephanie Christenson, MD, talk about personalized treatment approaches and the role of biologics in advanced COPD care.